Savara (SVRA) Gains from Sales and Divestitures (2016 - 2026)
Savara (SVRA) reported Gains from Sales and Divestitures of $125000.0 for Q1 2026, down 50.98% year-over-year from $255000.0 in Q1 2025, and down 94.18% on a QoQ basis from $2.1 million in Q4 2025.
Savara (SVRA) has 11 years of Gains from Sales and Divestitures data on file, last reported at $125000.0 in Q1 2026.
- Quarterly Gains from Sales and Divestitures fell 50.98% year-over-year to $125000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $125000.0 (down 50.98% YoY) and the FY2025 annual result came in at $2.1 million, up 92.17% from the prior year.
- Gains from Sales and Divestitures slipped to $125000.0 in Q1 2026 per SVRA's latest filing, from $2.1 million in the prior quarter.
- Across five years, Gains from Sales and Divestitures topped out at $2.1 million in Q4 2025 and bottomed at $1562.0 in Q2 2024.
- The 5-year median for Gains from Sales and Divestitures is $76563.0 (2024), against an average of $324077.3.
- The widest annual swing landed in 2022, when Gains from Sales and Divestitures plunged 99.11%; it then surged 16214.78% in 2025.
- Tracing SVRA's Gains from Sales and Divestitures over 5 years: stood at $9125.0 in 2022, then soared by 11538.36% to $1.1 million in 2023, then advanced by 5.25% to $1.1 million in 2024, then soared by 92.17% to $2.1 million in 2025, then sank by 94.18% to $125000.0 in 2026.
- Per Business Quant, the three latest SVRA Gains from Sales and Divestitures figures stand at $125000.0 (Q1 2026), $2.1 million (Q4 2025), and $400000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Savara | 1.30 Bn | 1.30 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 125,000.00 |
| Mar 31, 2026 | 125,000.00 |
| Dec 31, 2025 | 2.15 Mn |
| Dec 31, 2025 | 2.15 Mn |
| Sep 30, 2025 | 400,000.00 |
| Sep 30, 2025 | 400,000.00 |
| Jun 30, 2025 | 125,000.00 |
| Jun 30, 2025 | 125,000.00 |
| Mar 31, 2025 | 255,000.00 |
| Mar 31, 2025 | 255,000.00 |
| Dec 31, 2024 | 1.12 Mn |
| Dec 31, 2024 | 1.12 Mn |
| Sep 30, 2024 | 76,563.00 |
| Sep 30, 2024 | 76,563.00 |
| Jun 30, 2024 | 1,562.00 |
| Jun 30, 2024 | 1,562.00 |
| Mar 31, 2024 | 1,563.00 |
| Mar 31, 2024 | 1,563.00 |
| Dec 31, 2023 | 1.06 Mn |
| Dec 31, 2023 | 1.06 Mn |
| Sep 30, 2023 | 176,813.00 |
| Sep 30, 2023 | 176,813.00 |
| Jun 30, 2023 | 1,812.00 |
| Jun 30, 2023 | 1,812.00 |
| Mar 31, 2023 | 1,813.00 |
| Mar 31, 2023 | 1,813.00 |
| Dec 31, 2022 | 9,125.00 |
| Dec 31, 2022 | 9,125.00 |
| Sep 30, 2022 | 1,813.00 |
| Sep 30, 2022 | 1,813.00 |
| Jun 30, 2022 | 1,812.00 |
| Jun 30, 2022 | 1,812.00 |
| Mar 31, 2022 | 3,688.00 |
| Mar 31, 2022 | 3,688.00 |
| Dec 31, 2021 | 443,897.00 |
| Dec 31, 2021 | 443,897.00 |
| Sep 30, 2021 | 3,688.00 |
| Sep 30, 2021 | 3,688.00 |
| Jun 30, 2021 | 203,687.00 |
| Jun 30, 2021 | 203,687.00 |
| Mar 31, 2021 | 5,563.00 |
| Mar 31, 2021 | 5,563.00 |
| Dec 31, 2020 | 49,125.00 |
| Dec 31, 2020 | 49,125.00 |
| Sep 30, 2020 | 38,250.00 |
| Sep 30, 2020 | 38,250.00 |
| Jun 30, 2020 | 12,750.00 |
| Jun 30, 2020 | 12,750.00 |
| Mar 31, 2020 | 12,750.00 |
| Mar 31, 2020 | 12,750.00 |
| Dec 31, 2019 | 52,125.00 |
| Dec 31, 2019 | 52,125.00 |
| Sep 30, 2019 | 39,375.00 |
| Sep 30, 2019 | 39,375.00 |
| Jun 30, 2019 | 26,250.00 |
| Jun 30, 2019 | 26,250.00 |
| Mar 31, 2019 | 13,125.00 |
| Mar 31, 2019 | 13,125.00 |
| Dec 31, 2018 | 16,190.00 |
| Dec 31, 2018 | 16,190.00 |
| Sep 30, 2018 | 37,500.00 |
| Sep 30, 2018 | 37,500.00 |
| Jun 30, 2018 | 24,375.00 |
| Jun 30, 2018 | 24,375.00 |
| Mar 31, 2018 | 11,250.00 |
| Mar 31, 2018 | 11,250.00 |
| Dec 31, 2017 | 73,176.00 |
| Dec 31, 2017 | 73,176.00 |
| Sep 30, 2017 | 72,361.00 |
| Sep 30, 2017 | 72,361.00 |
| Jun 30, 2017 | 72,361.00 |
| Jun 30, 2017 | 72,361.00 |
| Dec 31, 2016 | 72,402.00 |
| Dec 31, 2016 | 72,402.00 |